PR Newswire Asia's news > Biotechnology

< Previous page

All Airlines/Aviation Auto Maritime/Shipbuilding Transportation Computer Hardware Computer Networks Computer Software Computer/Electronics Electronic Commerce Electronic Components High Tech Security Internet Technology Peripherals Semiconductors Electronics Gaming Consumer Electronics Mobile Entertainment Multimedia/Online/Internet Telecommunications Household/Consumer/Cosmetics Retail Supermarkets Toys Alternative Energies Chemical Mining/Metals Oil/Energy Environmental Products & Services Green Technology Art Cosmetics & Personal Care Entertainment Fashion Film & Motion Picture Jewelry Banking/Financial Service Insurance Workforce Management/Human Resources Education Higher Education Biotechnology Health Care/Hospital Infectious Disease Control Medical Equipment Medical/Pharmaceuticals Agriculture Machinery Paper/Forest Products/Containers Textiles Domestic policy Legal issues Sports Hotels and Resorts Leisure/Travel/Hotels Travel Restaurants Beer, Wine & Spirits Beverages Non-Alcoholic Beverages Food/Beverages Advertising Books Music Publishing/Information Service Television Trade show news Real Estate Construction/Building Furniture & Furnishings  |   Title only   |   Print

Next page >

88IV - PR Newswire Asia's news - Biotechnology 5 Innovent Announces First Patient Dosed in Phase 1 Study of IBI3020, Global First-in-class Dual Payload CEACAM5 ADC, in Patients with Advanced Malignancies SAN FRANCISCO and SUZHOU, China , April 30, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and ... 2025-04-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  Everest Medicines Announces New Drug Application Approval of VELSIPITY® for Adults with Moderately to Severely Active Ulcerative Colitis in Hong Kong SHANGHAI , April 30, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, ... 2025-04-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  Henlius Enters into License Agreement with Sandoz for Proposed Ipilimumab Biosimilar Partnership covers North America, Europe, Japan, and Australia to accelerate global access of HLX13 in immuno-oncology combinations Henlius to receive $31 million upfront, and up to $270 million in ... 2025-04-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  Henlius Enters into License Agreement with Sandoz for Proposed Ipilimumab Biosimilar Partnership covers North America, Europe, Japan, and Australia to accelerate global access of HLX13 in immuno-oncology combinations Henlius to receive $31 million upfront, and up to $270 million in ... 2025-04-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  PHASE Scientific Earns Prestigious Recognition at 2025 ASCCP Scientific Meeting for Innovation in Urine-Based HPV Screening SAN DIEGO , April 29, 2025 /PRNewswire/ -- PHASE Scientific (PHASE) proudly announced a major milestone this week with its inaugural participation and award-winning presentation at the 2025 American ... 2025-04-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals  Metabolon Launches Microbiome Research Solution Combining New Microbiome Panel, Metagenomics Sequencing, and Multiomics Bioinformatics Tools The combination of metagenomics and metabolomics data, integrated within an intuitive bioinformatics platform, enables deeper microbiome insights than possible with either approach individually ... 2025-04-29T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals  Driving Impact Through Responsibility: WuXi Biologics Releases 2024 Sustainability Report Contributing to United Nations Sustainable Development Goals Enhancing transparency and effectiveness for corporate governance Empowering employees and delivering positive impact to communities ... 2025-04-29T    Biotechnology   Environmental Products & Services   Health Care/Hospital   Medical/Pharmaceuticals  Amorepacific Research Confirms Potential of Microalgal-Derived PDRNs in Skin Regeneration and Wound Healing New findings suggest 'BluePDRN™' offers a sustainable, scalable alternative to traditional animal-derived PDRNs ... 2025-04-29T    Biotechnology   Cosmetics & Personal Care   Health Care/Hospital   Household/Consumer/Cosmetics  Juncell Therapeutics Announces Data on Feeder-free IL-2-Independent TIL Manufacturing Process at ASGCT Annual Meeting 2025 SHANGHAI , April 29, 2025 /PRNewswire/ -- Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech specializing in developing innovative IL-2-independent Tumor-Infiltrating ... 2025-04-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals   Trade show news  AI Evolution and Life Sciences: Embracing New Frontiers at Dalton Venture CEO Summit 2025  HONG KONG , April 29, 2025 /PRNewswire/ -- Dalton Venture CEO Summit 2025 , jointly hosted by Dalton Venture and Hong Kong Science and Technology Parks Corporation (HKSTP), successfully concluded ... 2025-04-29T    Banking/Financial Service   Biotechnology   Computer/Electronics   Health Care/Hospital
< Previous page	Next page >